<?xml version='1.0' encoding='utf-8'?>
<document id="25838319"><sentence text="Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review."><entity charOffset="65-77" id="DDI-PubMed.25838319.s1.e0" text="aripiprazole" /><entity charOffset="82-91" id="DDI-PubMed.25838319.s1.e1" text="clozapine" /><pair ddi="false" e1="DDI-PubMed.25838319.s1.e0" e2="DDI-PubMed.25838319.s1.e0" /><pair ddi="false" e1="DDI-PubMed.25838319.s1.e0" e2="DDI-PubMed.25838319.s1.e1" /></sentence><sentence text="Neuroleptic malignant syndrome (NMS) requires emergency treatment and can be fatal" /><sentence text=" Combined aripiprazole and clozapine therapy is rarely used in clinical settings, and NMS related this combination still lacks evaluation"><entity charOffset="10-22" id="DDI-PubMed.25838319.s3.e0" text="aripiprazole" /><entity charOffset="27-36" id="DDI-PubMed.25838319.s3.e1" text="clozapine" /><pair ddi="false" e1="DDI-PubMed.25838319.s3.e0" e2="DDI-PubMed.25838319.s3.e0" /><pair ddi="false" e1="DDI-PubMed.25838319.s3.e0" e2="DDI-PubMed.25838319.s3.e1" /></sentence><sentence text=" Herein, we present two cases of atypical NMS treated with aripiprazole and clozapine"><entity charOffset="59-71" id="DDI-PubMed.25838319.s4.e0" text="aripiprazole" /><entity charOffset="76-85" id="DDI-PubMed.25838319.s4.e1" text="clozapine" /><pair ddi="false" e1="DDI-PubMed.25838319.s4.e0" e2="DDI-PubMed.25838319.s4.e0" /><pair ddi="false" e1="DDI-PubMed.25838319.s4.e0" e2="DDI-PubMed.25838319.s4.e1" /></sentence><sentence text="" /><sentence text="Case 1 was a schizophrenic male with a history of NMS under treatment with aripiprazole 20 mg"><entity charOffset="75-87" id="DDI-PubMed.25838319.s6.e0" text="aripiprazole" /></sentence><sentence text=" He was hospitalized and maintained with aripiprazole 5 mg and clozapine 225 mg"><entity charOffset="41-53" id="DDI-PubMed.25838319.s7.e0" text="aripiprazole" /><entity charOffset="63-72" id="DDI-PubMed.25838319.s7.e1" text="clozapine" /><pair ddi="false" e1="DDI-PubMed.25838319.s7.e0" e2="DDI-PubMed.25838319.s7.e0" /><pair ddi="false" e1="DDI-PubMed.25838319.s7.e0" e2="DDI-PubMed.25838319.s7.e1" /></sentence><sentence text=" On the 25th day, atypical NMS occurred with rigidity, elevated creatine kinase, and stupor, which subsided with supportive therapy"><entity charOffset="64-72" id="DDI-PubMed.25838319.s8.e0" text="creatine" /></sentence><sentence text=" He was discharged under treatment with aripiprazole 15 mg and fluoxetine 60 mg"><entity charOffset="40-52" id="DDI-PubMed.25838319.s9.e0" text="aripiprazole" /><entity charOffset="63-73" id="DDI-PubMed.25838319.s9.e1" text="fluoxetine" /><pair ddi="false" e1="DDI-PubMed.25838319.s9.e0" e2="DDI-PubMed.25838319.s9.e0" /><pair ddi="false" e1="DDI-PubMed.25838319.s9.e0" e2="DDI-PubMed.25838319.s9.e1" /></sentence><sentence text=" Case 2 was a female with schizoaffective disorder without a history of NMS" /><sentence text=" She was hospitalized and maintained with clozapine 50 mg and aripirazole 30 mg"><entity charOffset="42-51" id="DDI-PubMed.25838319.s11.e0" text="clozapine" /><entity charOffset="62-73" id="DDI-PubMed.25838319.s11.e1" text="aripirazole" /><pair ddi="false" e1="DDI-PubMed.25838319.s11.e0" e2="DDI-PubMed.25838319.s11.e0" /><pair ddi="false" e1="DDI-PubMed.25838319.s11.e0" e2="DDI-PubMed.25838319.s11.e1" /></sentence><sentence text=" On the 11th day, atypical NMS occurred with mild fever, delirium, and rigidity, which subsided under supportive therapy" /><sentence text="" /><sentence text="Our cases highlight the atypical features of NMS in patients being treated with combined ari-piprazole and clozapine"><entity charOffset="89-102" id="DDI-PubMed.25838319.s14.e0" text="ari-piprazole" /><entity charOffset="107-116" id="DDI-PubMed.25838319.s14.e1" text="clozapine" /><pair ddi="false" e1="DDI-PubMed.25838319.s14.e0" e2="DDI-PubMed.25838319.s14.e0" /><pair ddi="false" e1="DDI-PubMed.25838319.s14.e0" e2="DDI-PubMed.25838319.s14.e1" /></sentence><sentence text=" Consciousness change, modest elevation of creatine kinase, and leukocytosis were the most consistent findings; hyperthermia accounts for only some of the cases" /><sentence text=" This is a reminder of the importance of earlier detection of the soft signs and atypical features of NMS under this combined treatment" /><sentence text="" /></document>